Placebo to montelukast

DRUG3 trials

Sponsors

Organon and Co, Guangzhou Medical University, CHA University

Conditions

Asthma, BronchialMild Persistent AsthmaNonasthmatic Eosinophilic Bronchitis

Phase 3

A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)

WithdrawnNCT00540839

Organon and CoAsthma, Bronchial

Start: 2007-11-30Updated: 2022-02-14

Phase 4

Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis

Guangzhou Medical UniversityNonasthmatic Eosinophilic Bronchitis

Start: 2010-06-30End: 2011-06-30Target: 63Updated: 2010-05-12

Unknown Phase

Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.

CompletedNCT01581710

CHA UniversityMild Persistent Asthma

Start: 2012-05-31End: 2015-12-31Updated: 2018-04-12

Related Papers

Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: a pilot study.

2012-07-2115 citations